Clinical Research Fellowship: Awardees & Reports

2014 – 2015 Fellowships

Co-targeting of AKT and the Androgen Receptor for Advanced Prostate Cancer

Michael Kolinsky

Fellow: Michael Kolinsky
Home Institute: University of Alberta Cross Cancer Institute, Edmonton, Alberta, Canada
Host Institute: The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK
Sponsor: Novartis  

2013 – 2014 Fellowships

Molecular resistance following personalised therapy in colorectal cancer (FOCUS-4 clinical fellow)

Tal Grenader

Fellow: Tal Grenader
Home Institute: Shaare Zedek Medical Centre, Jerusalem, Israel
Host Institute: UCL, Cancer Institute, University College London, United Kingdom
Sponsor: Novartis  

Metabolomic study in renal cell carcinoma (RCC): patterns of relapsed and follow up

Guillermo Antonio De Velasco Oria

Fellow: Guillermo Antonio De Velasco Oria
Home Institute: University Hospital 12 De Octubre, Medical Oncology, Madrid, Spain
Host Institute: Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
Sponsor: Novartis

2011-2012 Fellowships

Association between insulin resistance and pathologic response to neoadjuvant chemotherapy among women with operable hormone receptor negative breast cancer

 Alejandra Alonso

Fellow: Alejandra Armengol Alonso
Home Institute: Instituto Nacional De Ciencias Medicias y Nutricion, Mexico City, Mexico
Host Institute: Barcelona Hospital Universitari, Barcelona, Spain
Sponsor: Novartis

Download the report

2010-2011 Fellowships

Treatment of naïve and fludarabine-refractory CLL in the TCL-1 mouse model with IPI-926 and other hedgehog pathway inhibitors

Fellow: Michael Baumann
Home Institute: Department of Medical Oncology, Kantonsspital, St. Gallen, Switzerland
Host Institute:Laboratory of Molecular Biology and Immunology CLL, Dept of Haematology and Oncology, University of Cologne, Germany
Sponsor: ESMO

Prostate Cancer Genetics and targeted screening

Fellow: Elena Castro Marcos
Home Institute: Centro de Investigacion del Cancer, Hospital Universitario de Salamanca, Spain
Host Institute: Royal Marsden Hospital NHS Trust, and The institute of Cancer Research, London, United Kingdom
Sponsor: Novartis